Agilent Technologies Inc.
Agilent Technologies Announces Election of Directors and Furnishes Financial Exhibits
Summary
Agilent Technologies, Inc. held its Annual Meeting of Stockholders on March 13, 2025, where shareholders elected two new directors, Otis W. Brawley, M.D. and Mikael Dolsten, M.D., Ph.D., and approved several other proposals including the compensation of named executive officers and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2025. The company also furnished its financial statements and exhibits as part of the 8-K filing.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement